Cargando…
SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway
Mesenchymal stem cells (MSCs) are thought to have great potential in the therapy of acute liver injury. It is possible that these cells may be regulated by the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor-4 (CXCR4) signaling axis, which has been shown to promote stem cells migration...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563832/ https://www.ncbi.nlm.nih.gov/pubmed/32452221 http://dx.doi.org/10.1177/0963689720929992 |
_version_ | 1783595576261083136 |
---|---|
author | Xiu, Guanghui Li, Xiuling Yin, Yunyu Li, Jintao Li, Bingqin Chen, Xianzhong Liu, Ping Sun, Jie Ling, Bin |
author_facet | Xiu, Guanghui Li, Xiuling Yin, Yunyu Li, Jintao Li, Bingqin Chen, Xianzhong Liu, Ping Sun, Jie Ling, Bin |
author_sort | Xiu, Guanghui |
collection | PubMed |
description | Mesenchymal stem cells (MSCs) are thought to have great potential in the therapy of acute liver injury. It is possible that these cells may be regulated by the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor-4 (CXCR4) signaling axis, which has been shown to promote stem cells migration in the inflammation-associated diseases. However, the effects of SDF-1/CXCR4 axis on the MSCs-transplantation-based treatment for acute liver injury and the underlying mechanisms are largely unknown. In this study, we sought to determine whether SDF-1/CXCR4 would augment the therapeutic effect of bone marrow mesenchymal stem cells (BMSCs) by promoting their migration, which may result from activating the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway, in a rat acute liver injury model induced by lipopolysaccharide (LPS). We found that BMSCs transplantation markedly attenuated liver injury and improved the survival of LPS-treated rats. Of interest, overexpression of CXCR4 in BMSCs could substantially promote their migration both in vitro and in vivo, and result in even better therapeutic effects. This might be attributed to the activation of PI3K/Akt signaling pathway in BMSCs that is downstream of CXCR4, as demonstrated by the use of the CXCR4 antagonist AMD3100 and PI3K pathway inhibitor LY294002 assays in vitro and in vivo. Together, our results unraveled a novel molecular mechanism for the therapeutic effect of BMSCs for the treatment of acute liver injury, which may shed a new light on the clinical application of BMSCs for acute liver failure. |
format | Online Article Text |
id | pubmed-7563832 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-75638322020-10-26 SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway Xiu, Guanghui Li, Xiuling Yin, Yunyu Li, Jintao Li, Bingqin Chen, Xianzhong Liu, Ping Sun, Jie Ling, Bin Cell Transplant Original Article Mesenchymal stem cells (MSCs) are thought to have great potential in the therapy of acute liver injury. It is possible that these cells may be regulated by the stromal cell-derived factor-1 (SDF-1)/CXC chemokine receptor-4 (CXCR4) signaling axis, which has been shown to promote stem cells migration in the inflammation-associated diseases. However, the effects of SDF-1/CXCR4 axis on the MSCs-transplantation-based treatment for acute liver injury and the underlying mechanisms are largely unknown. In this study, we sought to determine whether SDF-1/CXCR4 would augment the therapeutic effect of bone marrow mesenchymal stem cells (BMSCs) by promoting their migration, which may result from activating the phosphoinositide 3-kinase (PI3K)/Akt signaling pathway, in a rat acute liver injury model induced by lipopolysaccharide (LPS). We found that BMSCs transplantation markedly attenuated liver injury and improved the survival of LPS-treated rats. Of interest, overexpression of CXCR4 in BMSCs could substantially promote their migration both in vitro and in vivo, and result in even better therapeutic effects. This might be attributed to the activation of PI3K/Akt signaling pathway in BMSCs that is downstream of CXCR4, as demonstrated by the use of the CXCR4 antagonist AMD3100 and PI3K pathway inhibitor LY294002 assays in vitro and in vivo. Together, our results unraveled a novel molecular mechanism for the therapeutic effect of BMSCs for the treatment of acute liver injury, which may shed a new light on the clinical application of BMSCs for acute liver failure. SAGE Publications 2020-05-26 /pmc/articles/PMC7563832/ /pubmed/32452221 http://dx.doi.org/10.1177/0963689720929992 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Original Article Xiu, Guanghui Li, Xiuling Yin, Yunyu Li, Jintao Li, Bingqin Chen, Xianzhong Liu, Ping Sun, Jie Ling, Bin SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway |
title | SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway |
title_full | SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway |
title_fullStr | SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway |
title_full_unstemmed | SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway |
title_short | SDF-1/CXCR4 Augments the Therapeutic Effect of Bone Marrow Mesenchymal Stem Cells in the Treatment of Lipopolysaccharide-Induced Liver Injury by Promoting Their Migration Through PI3K/Akt Signaling Pathway |
title_sort | sdf-1/cxcr4 augments the therapeutic effect of bone marrow mesenchymal stem cells in the treatment of lipopolysaccharide-induced liver injury by promoting their migration through pi3k/akt signaling pathway |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7563832/ https://www.ncbi.nlm.nih.gov/pubmed/32452221 http://dx.doi.org/10.1177/0963689720929992 |
work_keys_str_mv | AT xiuguanghui sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT lixiuling sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT yinyunyu sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT lijintao sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT libingqin sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT chenxianzhong sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT liuping sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT sunjie sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway AT lingbin sdf1cxcr4augmentsthetherapeuticeffectofbonemarrowmesenchymalstemcellsinthetreatmentoflipopolysaccharideinducedliverinjurybypromotingtheirmigrationthroughpi3kaktsignalingpathway |